Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions

Pain is a physiological condition that is generally experienced by almost all mothers in labor or pain during menstruation (dysmenorrhea). Pain causes tachycardia in the mother, increased oxygen consumption, lactic (lactic) acid production, hyperventilation with a risk of respiratory alkalosis, and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sri Rejeki, Achmad Solichan, Fitri Nuroini
Formato:	article
Lenguaje:	ID
Publicado:	Universitas Muhammadiyah Semarang 2021
Materias:	regiosacral counter-pressure interleukin 6 prostaglandin e 2 uterine contractions Nursing RT1-120
Acceso en línea:	https://doaj.org/article/42631c9acfb44e0998b474cb260d3e51
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:42631c9acfb44e0998b474cb260d3e51
record_format	dspace
spelling	oai:doaj.org-article:42631c9acfb44e0998b474cb260d3e512021-11-22T04:41:50ZMaternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions2615-166910.26714/mki.4.4.2021.291-297https://doaj.org/article/42631c9acfb44e0998b474cb260d3e512021-11-01T00:00:00Zhttps://jurnal.unimus.ac.id/index.php/MKI/article/view/8577https://doaj.org/toc/2615-1669Pain is a physiological condition that is generally experienced by almost all mothers in labor or pain during menstruation (dysmenorrhea). Pain causes tachycardia in the mother, increased oxygen consumption, lactic (lactic) acid production, hyperventilation with a risk of respiratory alkalosis, and increased skeletal muscle tension. Regiosarcal Counter Pressure is an effective therapy to reduce pain due to uterine contractions. Based on research that has been done, Regiosarcal counter-pressure therapy can reduce pain levels and has also been shown to slightly reduce prostaglandin (PGE-2) levels in an insignificant amount. Changes in PGE-2 are suspected to have an impact on the stimulant hormone Interleukin-6 (IL-6). This study aims to determine the levels of IL-6 and prostaglandins in the first stage of labor. The research method used quasi-experimental, with inclusion criteria of first-stage labor, no pelvic abnormalities and other abnormalities that hindered the process of vaginal delivery, primiparas, singleton pregnancies, the location of the head did not receive painkillers. The results obtained 25 respondents with an average age of 23.72 (± 2.89) years, the average concentration of IL-6 before therapy was 185.159 (± 3.76) pg/ml and the mean after therapy was 180.782 (± 22.05) pg. /ml, the mean concentration of PGE2 before treatment was 223.521 (± 72.73) pg/ml and the mean after treatment was 179.873 (± 110.61) pg/ml. Administration of regiosacral counter-pressure therapy did not significantly reduce the levels of the hormone IL-6 and prostaglandins in women who experienced uterine contractions.Sri RejekiAchmad SolichanFitri NuroiniUniversitas Muhammadiyah Semarangarticleregiosacral counter-pressureinterleukin 6prostaglandin e 2uterine contractionsNursingRT1-120IDMedia Keperawatan Indonesia, Vol 4, Iss 4, Pp 291-297 (2021)
institution	DOAJ
collection	DOAJ
language	ID
topic	regiosacral counter-pressure interleukin 6 prostaglandin e 2 uterine contractions Nursing RT1-120
spellingShingle	regiosacral counter-pressure interleukin 6 prostaglandin e 2 uterine contractions Nursing RT1-120 Sri Rejeki Achmad Solichan Fitri Nuroini Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
description	Pain is a physiological condition that is generally experienced by almost all mothers in labor or pain during menstruation (dysmenorrhea). Pain causes tachycardia in the mother, increased oxygen consumption, lactic (lactic) acid production, hyperventilation with a risk of respiratory alkalosis, and increased skeletal muscle tension. Regiosarcal Counter Pressure is an effective therapy to reduce pain due to uterine contractions. Based on research that has been done, Regiosarcal counter-pressure therapy can reduce pain levels and has also been shown to slightly reduce prostaglandin (PGE-2) levels in an insignificant amount. Changes in PGE-2 are suspected to have an impact on the stimulant hormone Interleukin-6 (IL-6). This study aims to determine the levels of IL-6 and prostaglandins in the first stage of labor. The research method used quasi-experimental, with inclusion criteria of first-stage labor, no pelvic abnormalities and other abnormalities that hindered the process of vaginal delivery, primiparas, singleton pregnancies, the location of the head did not receive painkillers. The results obtained 25 respondents with an average age of 23.72 (± 2.89) years, the average concentration of IL-6 before therapy was 185.159 (± 3.76) pg/ml and the mean after therapy was 180.782 (± 22.05) pg. /ml, the mean concentration of PGE2 before treatment was 223.521 (± 72.73) pg/ml and the mean after treatment was 179.873 (± 110.61) pg/ml. Administration of regiosacral counter-pressure therapy did not significantly reduce the levels of the hormone IL-6 and prostaglandins in women who experienced uterine contractions.
format	article
author	Sri Rejeki Achmad Solichan Fitri Nuroini
author_facet	Sri Rejeki Achmad Solichan Fitri Nuroini
author_sort	Sri Rejeki
title	Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
title_short	Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
title_full	Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
title_fullStr	Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
title_full_unstemmed	Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
title_sort	maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions
publisher	Universitas Muhammadiyah Semarang
publishDate	2021
url	https://doaj.org/article/42631c9acfb44e0998b474cb260d3e51
work_keys_str_mv	AT srirejeki maternalinterleukin6andprostaglandinlevelspostregiosacralcounterpressureaspaintherapyduetouterinecontractions AT achmadsolichan maternalinterleukin6andprostaglandinlevelspostregiosacralcounterpressureaspaintherapyduetouterinecontractions AT fitrinuroini maternalinterleukin6andprostaglandinlevelspostregiosacralcounterpressureaspaintherapyduetouterinecontractions
_version_	1718418156315213824

Maternal interleukin-6 and prostaglandin levels post-regiosacral counter-pressure as pain therapy due to uterine contractions

Ejemplares similares